
Symbiomics
High-performance agricultural biologicals using microbiome and genomic technologies.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor investor investor investor investor | €0.0 | round | |
* | N/A | Series A | |
Total Funding | 000k |
Related Content
Symbiomics is a Brazilian biotechnology company developing high-performance biological products for agriculture. Founded in 2021 by researchers Rafael Souza (CEO) and Jader Armanhi (COO), the company originated to translate advanced scientific knowledge into products that improve plant performance and reduce environmental impact. Both founders have a research background in the effects of beneficial microorganisms on plant health and development.
The company's core business revolves around its proprietary platform for discovering and developing next-generation biologicals. This platform utilizes microbiome technologies, large-scale microbe isolation, genomics, machine learning, and genome editing to identify and engineer robust microorganisms. These microbes are formulated into products that serve multiple functions, including biofertilization (enhancing nutrient availability), biostimulation (improving resilience to drought and heat), biocontrol (managing pests and diseases), and carbon sequestration. The business model involves co-developing these solutions through partnerships with other agricultural companies.
Symbiomics' key technology allows it to analyze thousands of microorganisms to find robust strains more efficiently than traditional methods. By sequencing microbial genomes, the company gains insights into the best combinations of microbes for specific agricultural applications. Products are designed for compatibility with existing agricultural practices, ensuring a long shelf-life and tolerance to environmental stressors. The first products from its collaborations are in the testing phase, with a market launch anticipated within the next three years.
Based in Florianópolis, Brazil, the startup has secured significant funding to advance its research and operations. After initial backing from Vesper Biotechnologies and raising R$15 million from investors including Arar Capital, Cazanga, and The Yield Lab Latam, Symbiomics closed a Series A round on June 25, 2025. The Series A was led by Corteva Agriscience's investment platform, Corteva Catalyst, marking its first investment in Brazil. This funding is aimed at scaling operations, accelerating product development, and expanding commercial partnerships.
Keywords: agricultural biotechnology, biologicals, microbiome solutions, microbial discovery, genome editing, biofertilizers, biostimulants, biocontrol, sustainable agriculture, crop nutrition, soil health, plant resilience, carbon sequestration, agtech, genomics, data-driven agriculture, microbial synergy, crop protection, nature-based solutions, microbial strain selection